Andrew S. Boyer, Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX), sold 66,872 shares at $9.05 ($605K) on 2025-08-12, disclosed to the SEC on 2025-08-13.
Open-market sale of $605k AMRX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.05 | 33,436 | $303K | 50.0% |
| 2 | $9.05 | 33,436 | $303K | 50.0% |
| Total | $9.05 avg | 66,872 | $605K | 100% |
| Filing → |
| AMRX | SELL | 2024-08-16 | $983K | — | Filing → |
| AMRX | SELL | 2023-08-15 | $242K | — | Filing → |
| AMRX | BUY | 2019-08-07 | $385K | — | Filing → |